Literature DB >> 21326709

Transjugular intrahepatic portosystemic shunts in patients with hepatic malignancy.

Michael J Wallace1, David C Madoff.   

Abstract

Since its first clinical application in 1988, the transjugular intrahepatic portosystemic shunt (TIPS) has emerged as a safe and effective means of managing patients with morbid portal hypertension. Despite the considerable body of literature on TIPS, portal decompression in patients with malignancy has not been sufficiently examined. These patients typically experience sequelae of portal hypertension that requires palliation. The purpose of this article is to review the reported experience with TIPS in patients with malignancy.

Entities:  

Keywords:  Hepatic neoplasm; interventional procedure; portal hypertension; portosystemic shunt

Year:  2005        PMID： 21326709      PMCID： PMC3036301          DOI： 10.1055/s-2005-925557

Source DB:  PubMed          Journal:  Semin Intervent Radiol        ISSN： 0739-9529            Impact factor:   1.513


  35 in total

1.  Transcaval TIPS: indications and anatomic considerations.

Authors:  G M Soares; T P Murphy
Journal:  J Vasc Interv Radiol       Date:  1999-10       Impact factor: 3.464

Review 2.  TIPSS 10 years on.

Authors:  R Jalan; H F Lui; D N Redhead; P C Hayes
Journal:  Gut       Date:  2000-04       Impact factor: 23.059

3.  Transjugular intrahepatic portosystemic shunt after complete obstruction of portal vein.

Authors:  T Yamagami; T Nakamura; O Tanaka; W Akada; T Takayama; T Maeda
Journal:  J Vasc Interv Radiol       Date:  1999-05       Impact factor: 3.464

4.  Portal venous thrombosis: percutaneous therapy and outcome.

Authors:  E M Walser; S W NcNees; O DeLa Pena; W N Crow; R A Morgan; R Soloway; T Broughan
Journal:  J Vasc Interv Radiol       Date:  1998 Jan-Feb       Impact factor: 3.464

5.  The successful treatment of symptomatic, refractory hepatic hydrothorax with transjugular intrahepatic portosystemic shunt.

Authors:  F D Gordon; H T Anastopoulos; W Crenshaw; B Gilchrist; N McEniff; K R Falchuk; J LoCicero; W D Lewis; R L Jenkins; C Trey
Journal:  Hepatology       Date:  1997-06       Impact factor: 17.425

6.  Transjugular intrahepatic portosystemic shunt patency and the importance of stenosis location in the development of recurrent symptoms.

Authors:  R S Saxon; P L Ross; J Mendel-Hartvig; R E Barton; K Benner; K Flora; B D Petersen; P C Lakin; F S Keller
Journal:  Radiology       Date:  1998-06       Impact factor: 11.105

7.  Randomised trial of transjugular-intrahepatic-portosystemic shunt versus endoscopy plus propranolol for prevention of variceal rebleeding.

Authors:  M Rössle; P Deibert; K Haag; A Ochs; M Olschewski; V Siegerstetter; K H Hauenstein; R Geiger; C Stiepak; W Keller; H E Blum
Journal:  Lancet       Date:  1997-04-12       Impact factor: 79.321

8.  A model to predict poor survival in patients undergoing transjugular intrahepatic portosystemic shunts.

Authors:  M Malinchoc; P S Kamath; F D Gordon; C J Peine; J Rank; P C ter Borg
Journal:  Hepatology       Date:  2000-04       Impact factor: 17.425

9.  A comparison of paracentesis and transjugular intrahepatic portosystemic shunting in patients with ascites.

Authors:  M Rössle; A Ochs; V Gülberg; V Siegerstetter; J Holl; P Deibert; M Olschewski; M Reiser; A L Gerbes
Journal:  N Engl J Med       Date:  2000-06-08       Impact factor: 91.245

10.  Encephalopathy after transjugular intrahepatic portosystemic shunting: analysis of incidence and potential risk factors.

Authors:  D A Zuckerman; M D Darcy; T P Bocchini; C F Hildebolt
Journal:  AJR Am J Roentgenol       Date:  1997-12       Impact factor: 3.959
View more
  2 in total

Review 1.  Balloon-Occluded Retrograde Transvenous Obliteration (BRTO) for Treatment of Gastric Varices: Review and Meta-Analysis.

Authors:  Jonathan K Park; Sammy Saab; Stephen T Kee; Ronald W Busuttil; Hyun J Kim; Francsico Durazo; Sung-Ki Cho; Edward Wolfgang Lee
Journal:  Dig Dis Sci       Date:  2014-12-18       Impact factor: 3.199

2.  Transjugular intrahepatic portosystemic shunt with covered stents for hepatocellular carcinoma with portal vein tumor thrombosis.

Authors:  Jian-Bo Zhao; Chao Feng; Qiao-Hua Zhu; Xiao-Feng He; Yan-Hao Li; Yong Chen
Journal:  World J Gastroenterol       Date:  2014-02-14       Impact factor: 5.742
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.